Using biomarkers to predict the presence of FAS mutations in patients with features of the autoimmune lymphoproliferative syndrome

Journal of Allergy and Clinical Immunology

Volumn 125, Issue 4, 2010, Pages

  Caminha, Iusta ^a   Fleisher, Thomas A ^a   Hornung, Ronald L ^b   Dale, Janet K ^a   Niemela, Julie E ^a   Price, Susan ^a   Davis, Joie ^a   Perkins, Katie ^b   Dowdell, Kennichi C ^a   Brown, Margaret R ^a   Rao, V Koneti ^a   Oliveira, João Bosco ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b SAIC FREDERICK INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CYANOCOBALAMIN; CYTOKINE; FAS ANTIGEN; IMMUNOGLOBULIN; INTERLEUKIN 10; INTERLEUKIN 18; TUMOR NECROSIS FACTOR ALPHA;

AUTOIMMUNE LYMPHOPROLIFERATIVE DISEASE; EOSINOPHIL COUNT; GENE MUTATION; HUMAN; IMMUNOPHENOTYPING; LETTER; LYMPHOPROLIFERATIVE DISEASE; PREDICTION; PRIORITY JOURNAL; VITAMIN BLOOD LEVEL;

EID: 77950368803     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaci.2009.12.983     Document Type: Letter

References (7)

1. Bidere N., Su H.C., and Lenardo M.J. Genetic disorders of programmed cell death in the immune system. Annu Rev Immunol 24 (2006) 321-352
2. Oliveira J.B., Bidere N., Niemela J.E., Zheng L., Sakai K., Nix C.P., et al. NRAS mutation causes a human autoimmune lymphoproliferative syndrome. Proc Natl Acad Sci U S A 104 (2007) 8953-8958
3. Sneller M.C., Straus S.E., Jaffe E.S., Jaffe J.S., Fleisher T.A., Stetler-Stevenson M., et al. A novel lymphoproliferative/autoimmune syndrome resembling murine lpr/gld disease. J Clin Invest 90 (1992) 334-341
4. Bleesing J.J., Brown M.R., Straus S.E., Dale J.K., Siegel R.M., Johnson M., et al. Immunophenotypic profiles in families with autoimmune lymphoproliferative syndrome. Blood 98 (2001) 2466-2473
5. Lopatin U., Yao X., Williams R.K., Bleesing J.J., Dale J.K., Wong D., et al. Increases in circulating and lymphoid tissue interleukin-10 in autoimmune lymphoproliferative syndrome are associated with disease expression. Blood 97 (2001) 3161-3170
6. Fuss I.J., Strober W., Dale J.K., Fritz S., Pearlstein G.R., Puck J.M., et al. Characteristic T helper 2 T cell cytokine abnormalities in autoimmune lymphoproliferative syndrome, a syndrome marked by defective apoptosis and humoral autoimmunity. J Immunol 158 (1997) 1912-1918
7. Magerus-Chatinet A., Stolzenberg M.C., Loffredo M.S., Neven B., Schaffner C., Ducrot N., et al. FAS-L, IL-10, and double-negative CD4- CD8- TCR alpha/beta+ T cells are reliable markers of autoimmune lymphoproliferative syndrome (ALPS) associated with FAS loss of function. Blood 113 (2009) 3027-3030